Scarica l'app Stockscreener
3.46
1.98%
-0.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.53
Aprire:
$3.48
Volume 24 ore:
146.36K
Relative Volume:
0.26
Capitalizzazione di mercato:
$105.51M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-2.4714
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
-1.14%
1M Prestazione:
-8.47%
6M Prestazione:
-40.34%
1 anno Prestazione:
-72.99%
Intervallo 1D:
$3.44
$3.57
Intervallo di 1 settimana:
$3.325
$3.617
Portata 52W:
$3.325
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.46 | 107.64M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-20 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2025-08-08 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
What analysts say about AVITA Medical Inc stockFundamental Stock Analysis & Outstanding Portfolio Growth - earlytimes.in
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Can AVITA Medical Inc. stock sustain revenue growthJuly 2025 Volume & Reliable Price Breakout Alerts - Newser
Highs Report: Is AVITA Medical Inc stock in correction or buying zone2025 Key Lessons & Low Drawdown Trading Strategies - moha.gov.vn
CapEx per share of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA® Medical Reports Third Quarter 2025 Financial Results - ADVFN
Tangible book value per share of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference - Investing News Network
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference - The Manila Times
Avita Medical (NASDAQ:RCEL) Upgraded at BTIG Research - MarketBeat
Why AVITA Medical Inc. stock is favored by top institutionsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
BTIG Upgrades AVITA Medical (RCEL) - Nasdaq
AVITA Medical Inc (RCEL) Stock News & Articles - 24/7 Wall St.
RCEL Upgraded by BTIG: New Neutral Rating | RCEL Stock News - GuruFocus
BTIG upgrades Avita Medical stock rating to Neutral from Sell By Investing.com - Investing.com Canada
AVITA Medical Inc : Btig Raises to Neutral Fr - 富途牛牛
How AVITA Medical Inc. stock performs in high volatility marketsMarket Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Investors to Connect - ACCESS Newswire
Will AVITA Medical Inc. stock benefit from commodity pricesMarket Rally & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in AVITA Medical Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Historical volatility pattern of AVITA Medical Inc. visualizedMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Q2 2025 AVITA Medical Inc Earnings Call Transcript - GuruFocus
Is AVITA Medical Inc. stock attractive for income investors2025 Price Action Summary & High Return Trade Guides - newser.com
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Why AVITA Medical Inc. stock remains a top recommendationWeekly Trade Report & Community Verified Trade Alerts - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cycles2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
How AVITA Medical Inc. stock performs in weak economyWeekly Market Report & Comprehensive Market Scan Reports - newser.com
How analysts rate AVITA Medical Inc. stock todayJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Connect - ACCESS Newswire
Brokers Offer Predictions for Avita Medical FY2025 Earnings - MarketBeat
How AVITA Medical Inc. stock performs in interest rate cyclesQuarterly Portfolio Report & AI Powered Market Entry Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Reach Out - ACCESS Newswire
AVITA Medical (RCEL) Q3 2025 Earnings Transcript - AOL.com
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avita Medical Inc Azioni (RCEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
0.52%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):